health-care Logo
MabVax Therapeutics logo

Working At MabVax Therapeutics

Zippia Score 3.8

MabVax Therapeutics overview

We generate our pipeline of antibody based product candidates from patients who have been vaccinated with the proprietary vaccines we have licensed from Memorial Sloan-Kettering Cancer Center (MSKCC). Our unique approach of surveying the protective im...
Based in San Diego, California, MabVax Therapeutics is a small technology company with only 25 employees and an annual revenue of $5.5M.

Industry

Biotechnology

Revenue

$5.5M

Employees

25

Founded in

2006

Headquarters

San Diego, CA

Website

mabvax.com

Website

mabvax.com

Organization Type

Private

Is This Your Company?

The team at MabVax Therapeutics

Key People
  • Jeffrey Eisenberg (Director)
  • Gregory Hanson (Executive Officer)
  • Thomas Varvaro (Director)
  • Philip Livingston (Director)
  • Paul Maffuid (Executive Officer)
  • Paul Resnick (Executive Officer)
  • Paul Maier (Director)
  • David Hansen (Executive Officer, Director)
  • Kenneth Cohen (Director)

What do people say about MabVax Therapeutics

Work at MabVax Therapeutics ? Share your experience anonymously.

What do you like about working for MabVax Therapeutics?

00

Do you Work At MabVax Therapeutics?

Help us make this company more transparent.

0

MabVax Therapeutics Financial Performance

7.1
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$5M - $10M

Founded in

2006

Organization type

Private

MabVax Therapeutics Financing Rounds

DateAmount
May 15, 2018Equity
$860,000
Feb 13, 2018Equity
$2,750,000
Apr 9, 2015Equity
$15,000,000
Jul 10, 2014Equity
$10,000,000
Feb 25, 2014Equity
$15,089,998
Sep 2, 2009Equity
$3,999,998

How Would You Rate The Company Culture Of MabVax Therapeutics?

Have you worked at MabVax Therapeutics? Help other job seekers by rating MabVax Therapeutics.

MabVax Therapeutics Competitors

Frequently Asked Questions about MabVax Therapeutics

When was MabVax Therapeutics founded?

MabVax Therapeutics was founded in 2006.

How many Employees does MabVax Therapeutics have?

MabVax Therapeutics has 25 employees.

How much money does MabVax Therapeutics make?

MabVax Therapeutics generates $5.5M in revenue.

What industry is MabVax Therapeutics in?

MabVax Therapeutics is in the biotechnology industry.

What type of company is MabVax Therapeutics?

MabVax Therapeutics is a private company.

Who are MabVax Therapeutics's competitors?

MabVax Therapeutics competitors include Ligand Pharmaceuticals, Inovio Pharmaceuticals, Acambis, Sangamo Therapeutics, BioSurfaces, XBiotech, Taxon Biosciences, Neuralstem, Five Prime Therapeutics, American Health Foundation, Odyssey Thera, Aileron Therapeutics, IOMAI, PROTEOGENIX, METABOLIX, Agenus, Targeted Growth, Molecular Science, 3-V Biosciences, Avalon Pharmaceuticals.

Who works at MabVax Therapeutics?

Jeffrey Eisenberg (Director)

Gregory Hanson (Executive Officer)

Thomas Varvaro (Director)

Show More

Where is MabVax Therapeutics's headquarters?

MabVax Therapeutics's headquarters is in San Diego, CA.

Are you an executive, HR leader, or brand manager at MabVax Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at MabVax Therapeutics, also known as MABVAX THERAPEUTICS HLDGS INC, MABVAX THERAPEUTICS HOLDINGS, INC., MabVax Therapeutics, MabVax Therapeutics Holdings Inc, MabVax Therapeutics Holdings, Inc. and MabVax Therapeutics, Inc..

Zippia gives an in-depth look into the details of MabVax Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MabVax Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at MabVax Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of MabVax Therapeutics and its employees or that of Zippia.